|
PIGQ expression based on
|
Statistics: Unpaired two sample T-test was employed to evaluate levels of significance in expression level between any two sample groups
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.49150000028753E-07 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.09059999999317E-05 |
| Normal-vs-Stage2 |
1.76982999999797E-05 |
| Normal-vs-Stage3 |
4.779600E-03 |
| Normal-vs-Stage4 |
5.926200E-02 |
| Stage1-vs-Stage2 |
1.193570E-02 |
| Stage1-vs-Stage3 |
7.862200E-01 |
| Stage1-vs-Stage4 |
5.586600E-01 |
| Stage2-vs-Stage3 |
1.106200E-02 |
| Stage2-vs-Stage4 |
1.427700E-02 |
| Stage3-vs-Stage4 |
7.620000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.89259999999947E-05 |
| Normal-vs-AfricanAmerican |
5.334100E-02 |
| Normal-vs-Asian |
2.658700E-03 |
| Caucasian-vs-AfricanAmerican |
9.701400E-01 |
| Caucasian-vs-Asian |
5.530400E-01 |
| AfricanAmerican-vs-Asian |
6.498000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.91910000002515E-06 |
| Normal-vs-Female |
4.4333000000063E-05 |
| Male-vs-Female |
3.477600E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.017400E-04 |
| Normal-vs-Age(41-60Yrs) |
1.51336999999474E-05 |
| Normal-vs-Age(61-80Yrs) |
7.554900E-04 |
| Normal-vs-Age(81-100Yrs) |
4.158200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.396000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.654400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.855200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.131400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.383000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.462000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.638400E-04 |
| Classical-VS-Follicular |
4.16680000003833E-06 |
| Classical-VS-Other |
7.397200E-01 |
| Classical-VS-Normal |
1.183330E-04 |
| Tall-VS-Follicular |
8.96499996461131E-09 |
| Tall-VS-Other |
5.929700E-02 |
| Tall-VS-Normal |
4.031200E-01 |
| Follicular-VS-Other |
2.814000E-01 |
| Follicular-VS-Normal |
1.0373002456987E-10 |
| Other-VS-Normal |
2.503600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.2634999713157E-09 |
| Normal-vs-N1 |
5.226200E-02 |
| N0-vs-N1 |
1.152620E-01 |
|
|
